Broker Recommendations Valneva SE

Stocks

VLA

FR0004056851

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 20/07/2026 BST			After hours 18:00:20
2.130 ^EUR	-1.21%		2.138	+0.38%

06-30	Certain Ordinary Shares of Valneva SE are subject to a Lock-Up Agreement Ending on 30-JUN-2026.	CI
06-26	European Medicines Agency Panel Recommends Change to Valneva's Chikungunya Vaccine Marketing Approval	MT

Broker Recommendations

05-13	French Analyst Ratings: Aramis and Valneva penalized following profit warnings
04-22	Goldman Sachs Downgrades Valneva to Sell From Neutral, Adjusts Price Target to $4.90 From $7.50	MT
04-22	French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight
03-18	Valneva heads for fourth consecutive gain following annual results
01-20	Stifel Reiterates Buy Rating and Price Target on Valneva
01-06	Valneva, Biggest Gainer on SBF 120 and SRD at Close of Tuesday, January 6, 2026
01-06	Valneva Surges on Positive Broker Comments
01-06	CAC 40 Lags Behind; Valneva in Demand
01-06	Valneva Posts Strongest Midday Gain on SBF 120, Tuesday, January 6, 2026
01-06	Stock of the Day in Paris – Valneva Bolstered by Stifel
01-06	Stifel Raises Price Target for Valneva
11-20	Stifel Reiterates Buy Recommendation on Valneva
11-04	Valneva SE Announces Positive Results of Its Phase 1 Clinical Trial Investigating the Safety and Immunogenicity of VLA1601	CI
03/09/25	Valneva publishes positive data for its Lyme disease vaccine candidate, stock rises	RE
26/08/25	Valneva: Stifel Adjusts Price Target Following FDA Suspension of Ixchiq License
26/08/25	Valneva: Stifel adjusts target price
12/08/25	Valneva: Oddo BHF confirms 'outperform' rating
14/07/25	Valneva Shares Surge After EMA Lifts Restriction on Chikungunya Vaccine	RE
13/08/24	Valneva: Oddo BHF confirms its recommendation on the stock
24/06/24	Valneva rises after Canadian approval for its chikungunya vaccine	RE
05/02/24	Valneva: Oddo BHF confirms its recommendation on the stock
02/01/24	Valneva: Oddo BHF remains positive
10/11/23	HC Wainwright Adjusts Price Target on Valneva SE to $26 From $22, Maintains Buy Rating	MT
08/11/23	Valneva: share price in demand on eve of earnings release
14/08/23	Valneva falls after FDA postpones review date for its Chikungunya vaccine	RE